441 |
SOS: Randomized Trials of Paclitaxel-Eluting vs. BMS in SVG Lesions |
Emmanouil Brilakis |
Dec. 09. 08 |
440 |
ENDEAVOR IV: 2-Year FU Comparing Zotarolimus- vs. Paclitaxel-Eluting Stents |
Martin Bert Leon |
Dec. 09. 08 |
439 |
ISAR-LM: Randomized Comparison of Sirolimus-& Paclitaxel- Eluting Stents |
Julinda Mehilli |
Dec. 09. 08 |
438 |
Combined Use of Imaging and Computational Techniques to Investigate Fluid Dynamics in Normal and Stented Coronary Artery Bifurcations |
John LaDisa |
Dec. 05. 08 |
437 |
Evaluation of Microvascular Dysfunction |
Takashi Akasaka |
Dec. 05. 08 |
436 |
Relation Between Neointimal Coverage and Yellow Grade of the Segment after Sirolimus-Eluting Stent Evaluated by Coronary Angioscopy |
Junko Honye |
Dec. 05. 08 |
435 |
TRIAS HR Pilot Study Long Term Follow-Up |
Robbert De Winter |
Oct. 24. 08 |
434 |
Endothelial Progenitor Cell Capture Technology and Beyond |
Michael Kutryk |
Oct. 24. 08 |
433 |
Physiologic Insight of a Bifurcation Lesion |
Bon-Kwon Koo |
Oct. 10. 08 |
432 |
Identification of Vascular Responses to Coronary Stenting by Optical Coherence Tomography: A Sub-Analysis from the Japanese Multi-Center Safety Trial |
Mitsuyasu Terashima |
Oct. 10. 08 |